NRx Pharmaceuticals, Inc. (NRXP)
Largest Insider Buys in Sector
NRXP Stock Price History Chart
NRXP Stock Performance
About NRx Pharmaceuticals, Inc.
NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.
Insider Activity of NRx Pharmaceuticals, Inc.
Over the last 12 months, insiders at NRx Pharmaceuticals, Inc. have bought $128,722 and sold $0 worth of NRx Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at NRx Pharmaceuticals, Inc. have bought $273,251 and sold $915,701 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Javitt Jonathan C (Chief Scientist) — $194,800. Hurvitz Chaim (director) — $20,125. Gorovitz Aaron (director) — $11,197.
The last purchase of 70,000 shares for transaction amount of $20,125 was made by Hurvitz Chaim (director) on 2023‑08‑30.
List of Insider Buy and Sell Transactions, NRx Pharmaceuticals, Inc.
| 2023-08-30 | Hurvitz Chaim | director | 70,000 0.0777% | $0.29 | $20,125 | +8.83% | ||
| 2023-08-30 | Gorovitz Aaron | director | 35,000 0.0432% | $0.32 | $11,197 | +8.83% | ||
| 2023-08-23 | Javitt Jonathan C | Chief Scientist | 100,000 0.135% | $0.33 | $33,000 | +20.42% | ||
| 2023-08-22 | Javitt Jonathan C | Chief Scientist | 200,000 0.2614% | $0.32 | $64,400 | +12.58% | ||
| 2022-12-16 | Willard Stephen H | CHIEF EXECUTIVE OFFICER | 50,000 0.0773% | $1.17 | $58,500 | -55.52% | ||
| 2022-12-16 | VAN VOORHEES SETH | CHIEF FINANCIAL OFFICER | 30,000 0.0436% | $1.10 | $33,000 | -55.52% | ||
| 2022-12-07 | Sale | Javitt Jonathan C | director | 400,000 0.4224% | $1.00 | $400,000 | -63.19% | |
| 2022-11-30 | Sale | Javitt Daniel C. | director | 8,441 0.0134% | $1.50 | $12,700 | -60.42% | |
| 2022-11-29 | Sale | Javitt Daniel C. | director | 13,730 0.0228% | $1.50 | $20,651 | -58.70% | |
| 2022-11-28 | Flynn Patrick John | director | 6,750 0.0102% | $1.25 | $8,413 | -54.32% | ||
| 2022-11-25 | VAN VOORHEES SETH | CHIEF FINANCIAL OFFICER | 16,337 0.0241% | $1.11 | $18,215 | -49.65% | ||
| 2022-11-18 | Hurvitz Chaim | director | 40,408 0.0593% | $1.10 | $44,449 | -47.89% | ||
| 2022-11-17 | Sale | Javitt Daniel C. | director | 33,018 0.0433% | $1.05 | $34,745 | -51.07% | |
| 2022-11-17 | Hurvitz Chaim | director | 171,780 0.2312% | $1.08 | $185,522 | -51.07% | ||
| 2022-11-16 | Sale | Javitt Daniel C. | director | 133,719 0.1975% | $1.02 | $136,393 | -42.86% | |
| 2022-11-16 | Hurvitz Chaim | director | 287,812 0.4126% | $0.99 | $284,934 | -42.86% | ||
| 2022-11-11 | Sale | Javitt Daniel C. | director | 49,200 0.0753% | $1.01 | $49,510 | -38.75% | |
| 2022-07-29 | Sale | Javitt Daniel C. | 784,063 1.5019% | $1.01 | $791,433 | -6.94% | ||
| 2022-06-03 | Sale | Javitt Daniel C. | 115,657 0.1594% | $0.67 | $76,947 | +0.54% | ||
| 2022-06-01 | Javitt Jonathan C | Chief Scientist | 100,000 0.1543% | $0.58 | $58,000 | +29.02% |
Insider Historical Profitability
| Hurvitz Chaim | director | 570000 0.6693% | $2.41 | 4 | 0 | <0.0001% |
| Javitt Jonathan C | Chief Scientist | 446332 0.5241% | $2.41 | 3 | 1 | +29.02% |
| Gorovitz Aaron | director | 105000 0.1233% | $2.41 | 1 | 0 | |
| Javitt Daniel C. | director | 9634793 11.3128% | $2.41 | 0 | 7 | |
| Polar Asset Management Partners Inc. | 10 percent owner | 488036 0.573% | $2.41 | 0 | 1 | |
| ACKERMAN RICHARD | President and CEO | 225000 0.2642% | $2.41 | 1 | 1 | |
| Willard Stephen H | CHIEF EXECUTIVE OFFICER | 50000 0.0587% | $2.41 | 1 | 0 | <0.0001% |
| VAN VOORHEES SETH | CHIEF FINANCIAL OFFICER | 46337 0.0544% | $2.41 | 2 | 0 | <0.0001% |
| Flynn Patrick John | director | 40209 0.0472% | $2.41 | 1 | 0 | <0.0001% |
| Besthof Robert | Chief Comm. & Patient Officer | 23710 0.0278% | $2.41 | 0 | 1 | |
| Daigneault Alessandra | General Counsel & Secretary | 0 0% | $2.41 | 0 | 1 |
Institutional Investor Ownership
| The Vanguard Group | $679.56M | 13.46 | 1.44M | -0.35% | -$2.42M | 0.01 | |
| AdvisorShares | $290.12M | 5.75 | 614,793 | -4.33% | -$13.14M | 25.14 | |
| Geode Capital Management | $198.24M | 3.93 | 419,954 | +1.95% | +$3.79M | 0.02 | |
| BlackRock | $137.19M | 2.72 | 290,714 | 0% | +$0 | <0.01 | |
| Renaissance Technologies | $89,000.00 | 1.76 | 188,780 | -5.84% | -$5,515.94 | <0.0001 | |
| Bridgeway Capital Management | $57.9M | 1.15 | 122,700 | 0% | +$0 | 1.08 | |
| State Street | $53.91M | 1.07 | 114,240 | 0% | +$0 | <0.01 | |
| Northern Trust | $35.39M | 0.7 | 74,996 | 0% | +$0 | 0.01 | |
| Texas Capital Bank Wealth Management Services Inc | $29.87M | 0.59 | 63,290 | 0% | +$0 | 3.21 | |
| Morgan Stanley | $20.74M | 0.41 | 43,948 | -0.87% | -$182,152.86 | <0.01 | |
| Charles Schwab | $20.64M | 0.41 | 43,732 | 0% | +$0 | 0.01 | |
| Xtx Topco Ltd | $18.59M | 0.37 | 39,396 | New | +$18.59M | 1.02 | |
| Jane Street Capital | $13.06M | 0.26 | 27,685 | New | +$13.06M | 0.01 | |
| Tower Research Capital | $10.11M | 0.2 | 21,426 | +8.78% | +$816,554.19 | 0.1 | |
| United Asset Strategies, Inc. | $8.64M | 0.17 | 18,300 | 0% | +$0 | 0.86 | |
| UBS | $7.82M | 0.16 | 16,571 | -64.62% | -$14.28M | <0.01 | |
| LINSCO PRIVATE LEDGER CORP | $6.88M | 0.14 | 14,568 | 0% | +$0 | <0.01 | |
| BNY Mellon | $4.78M | 0.1 | 10,129 | 0% | +$0 | <0.01 | |
| IEQ Capital | $4.72M | 0.09 | 10,000 | 0% | +$0 | 0.07 | |
| Newedge Advisors Llc | $2.75M | 0.05 | 5,825 | -18.25% | -$613,510.73 | 0.03 | |
| Wells Fargo | $2.56M | 0.05 | 5,429 | +0.24% | +$6,134.83 | <0.01 | |
| Cutler Group Lp | $1,000.00 | 0.03 | 3,220 | 0% | +$0 | <0.01 | |
| Advisor Group Holdings Inc | $472,000.00 | 0.01 | 1,000 | 0% | +$0 | <0.01 | |
| Group One Trading | $428,000.00 | 0.01 | 907 | -95.27% | -$8.61M | 0.01 | |
| JPMorgan Chase | $232,000.00 | 0.01 | 492 | -97.07% | -$7.7M | <0.0001 | |
| Larson Financial Group Llc | $103,000.00 | <0.01 | 218 | 0% | +$0 | 0.01 | |
| Simplex Trading Llc | $0 | <0.01 | 195 | New | +$0 | <0.0001 | |
| Qube Research & Technologies | $78,000.00 | <0.01 | 165 | 0% | +$0 | <0.0001 | |
| Royal Bank of Canada | $0 | <0.01 | 125 | -99.92% | -$0 | <0.0001 | |
| Fidelity Investments | $52,000.00 | <0.01 | 110 | New | +$52,000.00 | <0.0001 |